Edward Sitar, CFO at Cancer Genetics, holds 67.80K shares in 9 Meters Biopharma (Ticker: NMTR), holds 17.50K shares in Cancer Genetics (Ticker: CGIX), holds ― shares in Timber Pharmaceuticals (Ticker: TMBR).

See the Hottest Stocks Based on Insider Trading >

Edward Sitar
Cancer Genetics (CGIX)
CFO

Ranked #72,367 out of 78,624 Corporate Insiders

Profitable Transactions

0 out of 4 Profitable Transactions

Average Return

-45.40%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

62.95%

NMTR

37.05%

CGIX

0.00%

TMBR

A breakdown of Edward Sitar's holdings

See the Top Stocks by Insiders

Insider Roles

9 Meters Biopharma
(NMTR)

CFO

Cancer Genetics
(CGIX)

CFO

Timber Pharmaceuticals
(TMBR)

Director

Roles that Edward Sitar holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Cancer Genetics
(CGIX)

Rating:Informative Buy

Date:May 21, 2014 - May 21, 2015

Return:-2.20%

The most profitable trade made by Edward Sitar

See the Latest Stocks Traded by Insiders

Edward Sitar's Trading History

CGIX

Cancer Genetics

Nov 16, 2016

CFO

Informative Sell

5.17K

$42.70K

NMTR

9 Meters Biopharma

Jul 02, 2020

CFO

Uninformative Buy

―

$72.55K

TMBR

Timber Pharmaceuticals

―

Director

―

List of latest transactions for each holding click on a transaction to see Edward Sitar's performance on stock

See All Insider Trading from Today

Edward Sitar insider profile FAQ

What is the percentage of profitable transactions made by Edward Sitar?

The percentage of profitable transactions made by Edward Sitar is 0%.

What is the average return per transaction made by Edward Sitar?

The average return per transaction made by Edward Sitar is -45.40%.

What stocks does Edward Sitar hold?

Edward Sitar holds: CGIX, NMTR, TMBR stocks.

What was Edward Sitar’s latest transaction?

Edward Sitar latest transaction was an Uninformative Buy of ―.

What was Edward Sitar's most profitable transaction?

Edward Sitar’s most profitable transaction was an Informative Buy of CGIX stock on May 21, 2014. The return on the trade was -2.20%.

What is Edward Sitar's role in Cancer Genetics?

Edward Sitar's role in Cancer Genetics is CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Edward Sitar Insider Profile

Edward Sitar Cancer Genetics (CGIX)CFO